Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02671 | 34290096 | Sci Adv | Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. | 2021 | Details |
| A02672 | 34289945 | Metabolism | Preparing for the NASH epidemic: A call to action. | 2021 | Details |
| A02673 | 34289507 | Semin Liver Dis | Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities. | 2021 | Details |
| A02674 | 34289506 | Semin Liver Dis | Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02675 | 34289397 | J Hepatol | Maternal obesity increases the risk and severity of NAFLD in offspring. | 2021 | Details |
| A02676 | 34289181 | J Gastroenterol Hepatol | Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis. | 2021 | Details |
| A02677 | 34289064 | J Clin Endocrinol Metab | Hepatic Fat in Early Childhood Is Independently Associated With Estimated Insulin Resistance: The Healthy Start Study. | 2021 | Details |
| A02678 | 34288580 | United European Gastroenterol J | Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany. | 2021 | Details |
| A02679 | 34288010 | Hepatology | Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells. | 2021 | Details |
| A02680 | 34287533 | Arq Gastroenterol | VITAMIN B12 AND HOMOCYSTEINE LEVELS IN PATIENTS WITH NAFLD: A SYSTEMATIC REVIEW AND METANALYSIS. | 2021 | Details |
| A02681 | 34285567 | Int J Gen Med | Relationship Between Non-Alcoholic Fatty Liver Disease and Abdominal and Pericardial Adipose Tissue in Middle-Aged and Elderly Subjects. | 2021 | Details |
| A02682 | 34285335 | Exp Mol Med | Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue. | 2021 | Details |
| A02683 | 34284932 | Ultrasound Med Biol | Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. | 2021 | Details |
| A02684 | 34284789 | Nutr Metab (Lond) | Modulation and bioinformatics screening of hepatic mRNA-lncRNAs (HML) network associated with insulin resistance in prediabetic and exercised mice. | 2021 | Details |
| A02686 | 34284414 | Eur J Gastroenterol Hepatol | Heritability analysis of liver stiffness detected by ultrasound shear wave elastography: a twin study. | 2021 | Details |
| A02687 | 34282172 | Sci Rep | Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease. | 2021 | Details |
| A02688 | 34282076 | J Chin Med Assoc | Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. | 2021 | Details |
| A02689 | 34281337 | J Agric Food Chem | γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway. | 2021 | Details |
| A02690 | 34280991 | Int J Environ Res Public Health | Assessing Interactions between PNPLA3 and Dietary Intake on Liver Steatosis in Mexican-Origin Adults. | 2021 | Details |
| A02691 | 34280550 | Clin Gastroenterol Hepatol | Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02692 | 34280515 | Adv Drug Deliv Rev | Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. | 2021 | Details |
| A02693 | 34280397 | Eur J Pharmacol | Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4. | 2021 | Details |
| A02694 | 34280304 | Cochrane Database Syst Rev | Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A02695 | 34280073 | Tissue Barriers | Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD. | 2021 | Details |
| A02696 | 34279787 | Arch Pharm Res | Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. | 2021 | Details |
| A02697 | 34279051 | Obes Rev | Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease. | 2021 | Details |
| A02698 | 34279027 | Eur J Prev Cardiol | Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease. | 2022 | Details |
| A02699 | 34278728 | Physiol Rep | Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study. | 2021 | Details |
| A02700 | 34278170 | Hepatol Commun | Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory-Wide Cohort Study. | 2021 | Details |
| A02701 | 34278169 | Hepatol Commun | Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02702 | 34278168 | Hepatol Commun | STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes. | 2021 | Details |
| A02703 | 34277974 | Endocrinol Diabetes Metab | Impact of lifestyle Intervention on branched-chain amino acid catabolism and insulin sensitivity in adolescents with obesity. | 2021 | Details |
| A02704 | 34277668 | Front Med (Lausanne) | Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation. | 2021 | Details |
| A02705 | 34277667 | Front Med (Lausanne) | NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III. | 2021 | Details |
| A02706 | 34277666 | Front Med (Lausanne) | Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A02707 | 34277457 | Front Oncol | Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers. | 2021 | Details |
| A02708 | 34277236 | Cureus | The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A02709 | 34276380 | Front Pharmacol | Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1. | 2021 | Details |
| A02710 | 34276360 | Front Pharmacol | Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. | 2021 | Details |
| A02711 | 34276221 | Diabetes Metab Syndr Obes | Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02712 | 34276197 | Ann Gastroenterol | Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A02713 | 34276185 | Ann Gastroenterol | Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no? | 2021 | Details |
| A02714 | 34276153 | J Clin Exp Hepatol | Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link? | 2020 | Details |
| A02715 | 34275935 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | Changes of cardiolipin involve in the occurrence and development of mitochondrial dysfunction associated with non-alcoholic fatty liver disease. | 2021 | Details |
| A02716 | 34275749 | Hepatobiliary Pancreat Dis Int | Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment. | 2021 | Details |
| A02717 | 34275374 | J Int Med Res | Relationship between AGT rs2493132 polymorphism and the risk of coronary artery disease in patients with NAFLD in the Chinese Han population. | 2021 | Details |
| A02718 | 34275345 | Int J Immunopathol Pharmacol | Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach. | 2022 | Details |
| A02719 | 34274649 | Environ Pollut | Comparative effects of genistein and bisphenol A on non-alcoholic fatty liver disease in laying hens. | 2021 | Details |
| A02721 | 34273531 | J Nutr Biochem | Dietary egg white protein hydrolysate improves orotic acid-induced fatty liver in rats by promoting hepatic phospholipid synthesis and microsomal triglyceride transfer protein expression. | 2021 | Details |
| A02722 | 34273453 | Diabetes Res Clin Pract | The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression. | 2021 | Details |
| A02723 | 34273289 | Lancet Gastroenterol Hepatol | Sleep and liver disease: a bidirectional relationship. | 2021 | Details |
| A02724 | 34273192 | J Gastroenterol Hepatol | Insulin-like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease. | 2021 | Details |
| A02725 | 34272900 | Int J Eat Disord | Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A02726 | 34272738 | Hepatology | The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1. | 2021 | Details |
| A02727 | 34271043 | Int J Biol Macromol | Structural characterization of two novel polysaccharides from Gastrodia elata and their effects on Akkermansia muciniphila. | 2021 | Details |
| A02728 | 34270928 | Cell Metab | FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. | 2021 | Details |
| A02729 | 34270263 | J Proteome Res | Integration of Metabolomics and Transcriptomics Reveals Ketone Body and Lipid Metabolism Disturbance Related to ER Stress in the Liver. | 2021 | Details |
| A02730 | 34269534 | Korean J Radiol | Quantitative MRI Assessment of Pancreatic Steatosis Using Proton Density Fat Fraction in Pediatric Obesity. | 2021 | Details |
| A02731 | 34269508 | J Clin Hypertens (Greenwich) | Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease. | 2021 | Details |
| A02732 | 34268860 | Liver Int | NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. | 2021 | Details |
| A02733 | 34267042 | Curr Opin Infect Dis | The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease. | 2021 | Details |
| A02734 | 34266657 | Clin Radiol | The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study. | 2021 | Details |
| A02735 | 34265474 | Acta Biomater | Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply. | 2021 | Details |
| A02736 | 34265444 | Clin Gastroenterol Hepatol | Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study. | 2021 | Details |
| A02737 | 34265276 | Lancet Gastroenterol Hepatol | Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. | 2021 | Details |
| A02738 | 34265208 | Child Obes | Prediction of Nonalcoholic Fatty Liver Disease by Anthropometric Indices and Bioelectrical Impedance Analysis in Children. | 2021 | Details |
| A02739 | 34264552 | Vopr Pitan | [Pathogenetic mechanisms for the development of hematological disorders in induced fatty liver disease in Wistar rats and assessment of the regulatory effects of carnosine and α-lipoic acid]. | 2021 | Details |
| A02740 | 34263707 | Expert Rev Gastroenterol Hepatol | Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction. | 2021 | Details |
| A02741 | 34263075 | JGH Open | Validation of a two-step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis. | 2021 | Details |
| A02742 | 34263067 | JGH Open | Noninvasive measure of treatment response in non-alcoholic steatohepatitis: Insights from EMMINENCE and meta-analysis. | 2021 | Details |
| A02743 | 34262928 | Front Nutr | Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model. | 2021 | Details |
| A02744 | 34262716 | Food Sci Nutr | Effect of garlic powder supplementation on blood pressure and hs-C-reactive protein among nonalcoholic fatty liver disease patients: A randomized, double-blind, placebo-controlled trial. | 2021 | Details |
| A02745 | 34262330 | Int J Gen Med | Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A02746 | 34262313 | Diabetes Metab Syndr Obes | Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02748 | 34261740 | Diabetes | Mutations of NRG4 Contribute to the Pathogenesis of Nonalcoholic Fatty Liver Disease and Related Metabolic Disorders. | 2021 | Details |
| A02749 | 34261618 | Dig Liver Dis | PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center. | 2021 | Details |
| A02750 | 34260600 | PLoS One | Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease. | 2021 | Details |
| A02751 | 34260003 | Neurochem Res | Resveratrol Protects SH-SY5Y Cells Against Oleic Acid-Induced Glucolipid Metabolic Dysfunction and Cell Injuries Via the Wnt/β-Catenin Signalling Pathway. | 2021 | Details |
| A02752 | 34259747 | Rev Col Bras Cir | Is there a link between non-alcoholic fatty liver disease aspects and pancreatic cancer? Results of a case-matched study. | 2021 | Details |
| A02753 | 34259033 | J Am Heart Assoc | Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10-Year Period in Both Male and Female Subjects. | 2021 | Details |
| A02754 | 34258604 | Med (N Y) | A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. | 2021 | Details |
| A02755 | 34257827 | Oxid Med Cell Longev | Changes in Key Mitochondrial Lipids Accompany Mitochondrial Dysfunction and Oxidative Stress in NAFLD. | 2021 | Details |
| A02756 | 34257817 | Oxid Med Cell Longev | The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence. | 2021 | Details |
| A02757 | 34257694 | Evid Based Complement Alternat Med | Alleviative Effect of Ruellia tuberosa L. on Insulin Resistance and Abnormal Lipid Accumulation in TNF-α-Treated FL83B Mouse Hepatocytes. | 2021 | Details |
| A02758 | 34257427 | Nat Rev Gastroenterol Hepatol | Dietary carbohydrates and fats in nonalcoholic fatty liver disease. | 2021 | Details |
| A02759 | 34257374 | Sci Rep | Body weight gain rather than body weight variability associated with increased risk of nonalcoholic fatty liver disease. | 2021 | Details |
| A02760 | 34256994 | Hepatobiliary Pancreat Dis Int | LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver. | 2021 | Details |
| A02761 | 34255575 | Metab Syndr Relat Disord | Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey. | 2021 | Details |
| A02762 | 34254372 | Phytother Res | The effect of (Cornus mas L.) fruit extract on liver function among patients with nonalcoholic fatty liver: A double-blind randomized clinical trial. | 2021 | Details |
| A02764 | 34253010 | Diabetes Metab J | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus. | 2021 | Details |
| A02765 | 34252441 | Eur J Pharmacol | Ferroptosis as a new therapeutic opportunity for nonviral liver disease. | 2021 | Details |
| A02766 | 34251802 | J Agric Food Chem | Oleanolic Acid Targets the Gut-Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis. | 2021 | Details |
| A02767 | 34251031 | Aliment Pharmacol Ther | PRO-C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol-related liver disease. | 2021 | Details |
| A02768 | 34250613 | J Clin Periodontol | Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. | 2021 | Details |
| A02769 | 34250000 | Front Nutr | Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. | 2021 | Details |
| A02770 | 34249975 | Front Med (Lausanne) | Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD. | 2021 | Details |
| A02771 | 34249624 | Quant Imaging Med Surg | Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method. | 2021 | Details |
| A02772 | 34249621 | Quant Imaging Med Surg | Gender-specific liver aging and magnetic resonance imaging. | 2021 | Details |
| A02773 | 34249410 | Am J Cancer Res | Targeting the eicosanoid pathway in hepatocellular carcinoma. | 2021 | Details |
| A02774 | 34249302 | Ther Adv Chronic Dis | Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease. | 2021 | Details |